VENOMYX

venomyx-logo

Venomyx is bringing antivenom into the 21st century with the world’s first toxin-specific snake antivenom. Their solution will make antivenom treatment safe, effective, and affordable for the millions of snakebite victims per year around the world that are currently underserved.

#SimilarOrganizations #People #Financial #Event #Website #More

VENOMYX

Social Links:

Industry:
Biotechnology Emergency Medicine Therapeutics

Founded:
2015-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.venomyx.com

Total Employee:
1+

Status:
Active

Contact:
+1 858 531 8336

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt Global Site Tag


Similar Organizations

not_available_image

D2M Biotherapeutics

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

novopyxis-logo

Novopyxis

Novopyxis is a biotechnology company dedicated to the development of therapeutics and medical devices.

recensa-therapeutics-logo

Recensa Therapeutics

Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.

Current Employees Featured

phil-tan_image

Phil Tan
Phil Tan Director of Scientific Research @ VenomYx
Director of Scientific Research

dan-dempsey_image

Dan Dempsey
Dan Dempsey Founder & CEO @ VenomYx
Founder & CEO
2015-05-01

Founder


dan-dempsey_image

Dan Dempsey

deepankar-roy_image

Deepankar Roy

Investors List

sosv_image

SOSV

SOSV investment in Convertible Note - VenomYx

synbio-axlr8r_image

IndieBio

IndieBio investment in Convertible Note - VenomYx

synbio-axlr8r_image

IndieBio

IndieBio investment in Seed Round - VenomYx

sosv_image

SOSV

SOSV investment in Seed Round - VenomYx

Newest Events participated

indiebio-demo-day_event_image Participated in IndieBio Demo Day on 2017-02-09 as exhibitor

Official Site Inspections

http://www.venomyx.com

  • Host name: 172.67.166.236
  • IP address: 172.67.166.236
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "VenomYx"

VenomYx - Crunchbase Company Profile & Funding

Venomyx is bringing antivenom into the 21st century with the world’s first toxin-specific snake antivenom. Their solution will make antivenom treatment safe, effective, and affordable for the …See details»

Venomyx Therapeutics - LinkedIn

Venomyx is bringing antivenom into the 21st century with the world's first toxin-specific snake antivenom. Our solution will make antivenom treatment safe, effective, and affordable for the ...See details»

Venomyx Therapeutics Company Profile 2024: Valuation, Funding ...

Developer of novel antitoxin therapeutics designed to make snakebite treatment safe, effective, and affordable.See details»

Venomyx Therapeutics - Products, Competitors, Financials, …

Venomyx Therapeutics targets the global healthcare market, particularly addressing a critical public health issue identified by the World Health Organization. It is based in San Francisco, …See details»

VenomYx - Contacts, Employees, Board Members, Advisors

VenomYx is a therapeutics company dedicated to solving antivenom crisis through development of the world's first universal antivenom.See details»

Firm | SBIR

Towards this end, Venomyx Therapeutics, Inc. is working in collaboration with the Chang lab at UCSD to exploit a powerful platform to discover Synthetically Evolved Nbs (SENs) for high …See details»

Venomyx - Overview, News & Similar companies | ZoomInfo.com

View Venomyx (www.venomyx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

VenomYx - Funding, Financials, Valuation & Investors - Crunchbase

Nov 2, 2016 · VenomYx is a therapeutics company dedicated to solving antivenom crisis through development of the world's first universal antivenom.See details»

Award | SBIR

Towards this end, Venomyx Therapeutics, Inc. is working in collaboration with the Chang lab at UCSD to exploit a powerful platform to discover Synthetically Evolved Nbs (SENs) for high …See details»

Bacteria Are Brewing Up the Next Generation of Antivenoms

Mar 20, 2017 · For close to 100 years, antivenom production has been a laborious process of snake-milking and horse blood harvesting. But now, with synthetic biology and next-generation …See details»

Venomyx Therapeutics - Craft

Venomyx Therapeutics is a company that specializes in the development of antitoxins. It offers Vipax, an antivenom that uses recombinant antibody fragments to target the clinically …See details»

An Interview With Daniel Dempsey of Venomyx Therapeutics

Venomyx is using biotechnology to eliminate the use of animals from the process of producing antivenom, along with making it available in a portable, easy-to-use injector that makes it …See details»

VenomYx - Crunchbase

VenomYx is a therapeutics company dedicated to solving antivenom crisis through development of the world's first universal antivenom.See details»

Venomyx | VentureRadar

Website: http://www.venomyx.com/ Develops next-generation antitoxins, Vipaxâ„¢, using recombinant antibody fragments targeting snake venom toxins for Asia, Africa, South America …See details»

Crowdability - Equity Crowdfunding Research & Education

Venomyx Therapeutics is a medtech company developing an affordable, effective, portable antivenom for snake bites. The company’s solution requires just 1/10th the amount of …See details»

Venomyx Therapeutics on Wefunder - Kingscrowd

Mar 14, 2019 · Venomyx Therapeutics, with a valuation cap of $5 million, is raising crowdfunding on WeFunder. The company is developing Vipax, the world’s first broad-spectrum antivenom …See details»

VenomYx - Tech Stack, Apps, Patents & Trademarks - Crunchbase

VenomYx is a therapeutics company dedicated to solving antivenom crisis through development of the world's first universal antivenom.See details»

Venomyx Therapeutics Stock Price, Funding, Valuation, Revenue ...

Feb 10, 2017 · See Venomyx Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Venomyx Therapeutics's post-money valuation and …See details»

5 Top Pharma Startups Tackling Neglected Tropical Diseases

The US-based startup Venomyx Therapeutics develops a broad spectrum antivenom. The startup’s thermally-stable antivenom targets clinically-relevant toxins in snake venom using …See details»

Dan Dempsey - Founder & CEO @ VenomYx - Crunchbase

Dan Dempsey is the Founder & CEO at VenomYx. Dan Dempsey studied at University of California, San Diego. There is no recent news or activity for this profile.See details»

linkstock.net © 2022. All rights reserved